https://www.news-medical.net/news/20121219/Vismodegib-team-wins-Drug-Discovery-of-the-Year-award.aspx
Vismodegib team wins Drug Discovery of the Year award
Jun 18, 2019 - The British Pharmacological Society proudly announces that its first annual Drug Discovery of the Year award has been won by the discovery team developing...
team winsdrug discoveryof thevismodegibyear
https://www.ncbi.nlm.nih.gov/Structure/pdb/8HJE
8HJE: Vismodegib binds to the catalytical domain of human Ubiquitin-Specific Protease 28
https://pmc.ncbi.nlm.nih.gov/articles/PMC11845060/
Histologic changes of basal cell carcinomas during vismodegib treatment - PMC
We report a case of a 63-year-old man with a history of numerous basal cell carcinomas (BCCs) on vismodegib who developed a pink subcutaneous nodule that was...
basal cellhistologicchangescarcinomasvismodegib
https://www.rcsb.org/structure/8P14
RCSB PDB - 8P14: USP28 USP domain in complex with Vismodegib
USP28 USP domain in complex with Vismodegib
rcsb pdbuspdomaincomplexvismodegib
https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL473417
Compound: VISMODEGIB (CHEMBL473417) - ChEMBL
Report card for Compound VISMODEGIB (CHEMBL473417). C19H14Cl2N2O3S, Small molecule, ERIVEDGE, GDC-0449, NSC-747691, NSC-755986, VISMODEGIB.
compoundvismodegibchembl
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00546&r=1
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients with...
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients with Progressive Meningiomas
fak inhibitorvismodegibcapivasertib